Navigation Links
Unilens Vision Reports Record First Quarter Earnings and Royalty Income
Date:11/29/2007

First Quarter Net Income Increases 22% and Royalty Income Increases 29%

From Prior Year

LARGO, Fla., Nov. 29 /PRNewswire-FirstCall/ -- Unilens Vision Inc. (OTC Bulletin Board: UVICF) (TSX Venture Exchange: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the first quarter of FY2008.

Net sales, excluding royalty income, for the quarter ended September 30, 2007 increased to $1,673,361 compared with $1,604,776 in the quarter ending September 30, 2006, an increase of 4.3%. The increase was primarily the result of continued growth of the Company's C-Vue multifocal contact lenses, which increased approximately 11% in the current quarter, which was partially offset by sales of our replacement products lines that declined as expected.

Net Income for the quarter increased 22% to a record first quarter of $377,296, or $0.08 per diluted share, compared with $310,492, or $0.07 per diluted share in the prior-year period.

Royalty income for the quarter increased 28.6% to a record first quarter of $612,799 compared with $476,550 in the prior-year quarter. Sales of licensed products by our licensee Bausch & Lomb continue to accelerate, resulting in the record quarterly royalty.

Income before taxes for the quarter ended September 30, 2007 increased 20% to $616,501, compared with $515,183 in the prior-year quarter. After recording income tax expense of $239,205, Unilens reported net income of $377,296, or $0.08 per diluted share. In the first quarter of FY2007, the Company reported net income of $310,492, or $0.07 per diluted share, after recording income tax expense of $204,691.

"We are pleased with our first quarter operating results and are optimistic regarding the outlook for our operating results for the remainder of the current fiscal year," stated Michael J. Pecora, Chief Executive Officer of Unilens Vision Inc.,
'/>"/>

SOURCE Unilens Vision Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Unilens Names Eschenbach Optik Exclusive Worldwide Distributor of the UniVision(R) Low Vision Lens
2. Vision restoration therapy shown to improve brain activity in brain injured patients
3. Mouse vision has a rhythm all its own
4. HEI, Inc. Announces Sale of RFID Division Assets
5. QUANTEL Intends to Strengthen its Dermatology/ Aesthetics Division With the Acquisition of WaveLight Aesthetic GmbH
6. The aye-ayes have it: The preservation of color vision in a creature of the night
7. Can brain-injured, partially-blind stroke patients regain some of their lost vision?
8. HEI, Inc. Closes on Sale of RFID Division Assets
9. Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company
10. Colorado Medical School Receives Provisional Accreditation
11. Poor Senior Vision Often a Window on Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...oducts, home to sodium, study says , , ...lenty of sodium -- commonly known as salt -- in fo...should know that lower-fat foods can have much mor...inding of a report published online Monday by Con... 37 common supermarket items and found large amoun...
(Date:12/2/2008)...eld biopharmaceutical company, today announced tha...nvestigational product candidate, HZT 501, met all... fixed-dose combination product containing ibuprof...gnificant reduction in the incidence of non-steroi...astrointestinal (gastric and/or duodenal) ulcers i...
(Date:12/2/2008)...roPhage, Inc., http://www.microphage.com , annou...e company,s Board of Directors. Taussig was presi...rch Center in Denver, the nation,s leading institu... to 2006. His medical specialty,is pediatric pul...ensively and am impressed with its progress,in de...
(Date:12/2/2008)...-- In the wake of the deaths of two persons in pub...ern of abuse and neglect of those who have psychia...ndividuals is calling on the incoming Obama admini...als to institute widespread, substantive reforms i...would include raising standards and regulatory exp...
Breaking Medicine News(10 mins):Health News:High Salt Levels Common in Many Foods 2Health News:Horizon Therapeutics announces 2 pivotal HZT-501 Phase 3 trials meet primary endpoints 2Health News:MicroPhage Selects Lynn Taussig, MD for Board of Directors 2Health News:Tragedies Underscore Crisis in U.S. Public Mental Health System: National Advocacy Organization Demands Reforms 2Health News:Tragedies Underscore Crisis in U.S. Public Mental Health System: National Advocacy Organization Demands Reforms 3
...ngh set up a task force to fill up the healthcare ... lab technicians. The recruitment not only fills /...unemployed. The move is based on the recommendati...onal Commission on Macroeconomics and Health, high...
...d the lives of two children in Mumbai and many mor...ed at various hospitals. // Health authorities sai...to treat those 90-odd people who are undergoing tr... to hospitals Wednesday, particularly in south Mum...
...proved that decrease in the fine particulate air p...pulation. This drop in mortality rates was specifi...ory disease, according to Dr. Francine Laden, from...lained in a statement. Several epidemiologic studi...
...higher in the opinion of parents’ when compared to...as new research has pointed out that Australian Fo...ed to all other types of football. // The Aussie ...ports injuries, the second place being occupied by...
Other Medicine News:
(Date:11/26/2008)...., Nov. 26 Children who...gnificantly increased risk of developing mental il... a Mayo Clinic study published this month in Pedi...emy of Pediatrics. , , The retrospective st...ith strabismus (misaligned eyes) and compared them...
(Date:11/25/2008)...ss can improve recovery , , Audio and Web V...le on the Mayo Clinic News Blog. Please see the bo...ROCHESTER, Minn., Nov. 25 /PRNewswire-USNewswire/ ...patients don,t think they,re having a stroke -- an...ir condition worsens. The findings appear in the c...
(Date:11/25/2008)...ISCO, Calif., Nov. 25 Proteolix, I... novel therapeutics that target,protein degradati...ay,announced that data from two ongoing Phase 2 c... will be presented at the upcoming 50th Annual Mee... Carfilzomib is the first in a new class,of spec...
(Date:11/25/2008)...rolled in Clinical Trial to Assess Survival of Pat...pies for Unresectable Hepatocellular Carcinoma , ...ight Sciences Oncology, Inc. (LSO) today announced...clinical trial of Light Infusion Therapy(TM) (Litx...ar carcinoma (HCC), also known as hepatoma or prim...
Breaking Medicine Technology:Eye Divergence in Children Triples Risk of Mental Illness 2Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Micromet Added to NASDAQ Biotechnology Index 9384 1Micromet Added to NASDAQ Biotechnology Index 9384 2Micromet Added to NASDAQ Biotechnology Index 9384 3Micromet Added to NASDAQ Biotechnology Index 9384 4Fat Sensing Hormones Might Fight Obesity 30710 1Fat Sensing Hormones Might Fight Obesity 30710 2International workshop aims to boost public engagement work in developing countries 30707 1International workshop aims to boost public engagement work in developing countries 30707 2International workshop aims to boost public engagement work in developing countries 30707 3Rong Li Lab offers insight into adaptive ability of cells 6066 1Rong Li Lab offers insight into adaptive ability of cells 6066 2
...SBOURG, France and VANCOUVER, April 26, 2007,/PRNe.... , a global,specialty pharmaceutical and medical ...rom its European pivotal trial examining the,Vascu...ap(TM)"),will be presented today at a scientific f...fety and efficacy of the Vascular,Wrap(TM) for use...
...very promises to make retina, spinal cord and othe...TON, April 26, 2007 /PRNewswire/ -- Scientists at ...of Harvard Medical,School, have identified a key m...o the adult central nervous system. The,study foun... by,stem cells) has the ability to break down barr...
Other Medicine Technology:Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 2Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 3Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 4Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 5Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 6Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 7Schepens Scientists Identify Key to Integrating Transplanted Nerve,Cells Into Injured Tissue 2Schepens Scientists Identify Key to Integrating Transplanted Nerve,Cells Into Injured Tissue 3
...feature-packed projectors ideal for any practice. ...for longer life -- up to 2,000 hours under typical...tial cost with an incandescent illumination system.... And both provide exceptionally even illumination...
...cal design and utilizes a multi-layered, multi-coa... producing a measurable 20% increase in optical re...lity of the Ultra Series also results in a 20% inc...of view and a 14% increase in depth of field. A si...
With the touch of a button, the Marco Encore Automatic Chair quickly reclines from an upright position to a fully horizontal, flat-table mode-or anywhere in between.
Both the Marco Keratometer I and Keratometer II are one position instruments for objectively measuring corneal curvature. The keratometer II has the added feature of internal readings for the presbyo
Medicine Products: